An orthotopic murine model of sinonasal malignancy

Clinical Cancer Research

Volumn 14, Issue 22, 2008, Pages 7348-7357

  Gelbard, Alexander ^a,b   Kupferman, Michael E ^a   Jasser, Samar A ^a   Chen, Wantao ^c   El Naggar, Adel K ^a   Myers, Jeffrey N ^a   Hanna, Ehab Y ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOID CYSTIC CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MAXILLARY SINUS; MOUSE; NONHUMAN; NOSE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; SINONASAL TUMOR; SOFT PALATE; TUMOR MODEL; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; DISEASE MODEL; METASTASIS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; CARCINOMA, ADENOID CYSTIC; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NOSE NEOPLASMS;

EID: 58149348625     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0977     Document Type: Article

References (44)

1. Barnes L. Surgical pathology of the head and neck. 2nd ed. New York: Marcel Dekker; 2001.
2. Rice DS. Surgical therapy of the nasal cavity, ethmoid sinus and maxillary sinus tumors. In: Thawley SE, Panje W, Batsakis J, Lindberg, R, editors. Comprehensive management of head and neck tumors. 2nd ed. Philadelphia:WB Saunders; 1999.
3. Roush GC. Epidemiology of cancer of the nose and paranasal sinuses: current concepts. Head Neck Surg 1979;2:3-11.
4. Constantino MM. Cancer of the nasal vestibule, nasal cavity, and paranasal sinus - surgical management. In: Harrison RSL, Hong W, editors. Head and neck cancer, a multidisciplinary approach. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
5. McKay SP, Shibuya TY, Armstrong WB, et al. Cell carcinoma of the paranasal sinuses and skull base. Am J Otolaryngol 2007;28:294-301.
6. Camphausen K, Purow B, Sproull M, et al. Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions. Proc Natl Acad Sci U S A 2005;102:8287-92.
7. Nakamura T, Fidler IJ, Coombes KR. Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Res 2007;67:139-48.
8. Zaitseva M, Vollenhoven BJ, Rogers PA. In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol Hum Reprod 2006;12:187-207.
9. Deschavanne PJ, Fertil B. A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 1996;34:251-66.
10. Kenny PA, Bissell MJ. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer 2003;107:688-95.
11. Hara Y, Ogata Y, Shirouzu K. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis. J Exp Clin Cancer Res 2000;19:497-504.
12. Camphausen K, Purow B, Sproull M, et al. Orthotopic growth of human glioma cells quantitatively and qualitatively influences radiation-induced changes in gene expression. Cancer Res 2005;65:10389-93.
13. Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev 1994;13:209-22.
14. Dong Z, Radinsky R, Fan D, et al. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 1994;86:913-20.
15. Fidler IJ. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 1986;5:29-49.
16. Hoffman RM. Orthotopic is orthodox: why are orthotopic-transplant metastatic models different from all other models? J Cell Biochem 1994;56:1-3.
17. Baia GS, Dinca EB, Ozawa T, et al. An orthotopic skull base model of malignant meningioma. Brain Pathol 2007;18:172-9.
18. Takada Y, Noguchi T, Okabe T, Kajiyama M. Superoxide dismutase in various tissues from rabbits bearing the Vx-2 carcinoma in the maxillary sinus. Cancer Res 1982;42:4233-5.
19. Yura Y, Tsujimoto H, Kusaka J, Harada K, Yoshida H, Sato M. Induction of carcinomas and sarcomas by 9,10-dimethyl-1,2-benzanthracene administration into the hamster maxillary sinus. J Oral Pathol Med 1995;24:120-4.
20. He RG, Zhang XS, Wang Z, Zhang XL, Qiu WL. The establishment of cell lines of adenoid cystic carcinoma of human salivary glands (Acc-2, Acc-3) and a study of morphology. West Chin J Stomatol 1988;6:1-4.
21. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001;92:3012-29.
22. Suarez C, Llorente JL, Fernandez De Leon R, Maseda E, Lopez A. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004;26:136-44.
23. Ganly I, Patel SG, Singh B, et al. Craniofacial resection formalignant paranasal sinus tumors: report of an international collaborative study. Head Neck 2005;27:575-84.
24. Kim S, Park YW, Schiff BA, et al. An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice. Clin Cancer Res 2005;11:1713-21.
25. Fu XY, Besterman JM, Monosov A, Hoffman RM. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci U S A 1991;88:9345-9.
26. Furukawa T, Fu X, Kubota T, Watanabe M, Kitajima M, Hoffman RM. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res 1993;53:1204-8.
27. Oshinsky GS, Chen Y, Jarrett T, Anderson AE, Weiss GH. A model of bladder tumor xenografts in the nude rat. J Urol 1995;154:1925-9.
28. Onn A, Isobe T, Itasaka S, et al. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 2003;9:5532-9.
29. Myers JN, Holsinger FC, Jasser SA, Bekele BN, Fidler IJ. An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 2002;8:293-8.
30. Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 2008;87:14-32.
31. Burtness B, Goldwasser MA, Flood W, Mattar B, Forastiere AA. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 2005;23:8646-54.
32. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78.
33. Caponigro F, Milano A, Ottaiano A, Iaffaioli RV. Epidermal growth factor receptor as a major anticancer drug target. Expert Opin Ther Targets 2006;10:877-88.
34. Rehman AO, Wang CY. SDF-1a promotes invasion of head and neck squamous cell carcinoma by activating NF-κB. J Biol Chem 2008;283:19888-94.
35. Takada Y, Khuri FR, Aggarwal BB. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-κB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-κB-regulated gene expression and up-regulation of apoptosis. J Biol Chem 2004;279:26287-99.
36. Leeman RJ, Lui VW, Grandis JR. STAT3 as a therapeutic target in head and neck cancer. Expert Opin Biol Ther 2006;6:231-41.
37. Tao Z, Chen S, Wu Z, Xiao B, Liu J, Hou W. Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA. J Laryngol Otol 2005;119:92-6.
38. Sano D, Kawakami M, Fujita K, et al. Antitumor effects of ZD6474 on head and neck squamous cell carcinoma. Oncol Rep 2007;17:289-95.
39. Fujita K, Sano D, Kimura M, et al. Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma. Oncol Rep 2007;18:47-51.
40. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 1992;267:23439-42.
41. Johnson FM, Saigal B, Talpaz M, Donato NJ. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Clin Cancer Res 2005;11:6924-32.
42. Mandal M, Myers JN, Lippman SM, et al. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008;112:2088-100.
43. Malanchi I, Peinado H, Kassen D, et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 2008;452:650-3.
44. Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 1998;17:279-84.